Eagle Pharmaceuticals Inc
F:1E6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eagle Pharmaceuticals Inc
F:1E6
|
US |
|
Clabo SpA
MIL:CLABO
|
IT |
|
O
|
OptiNose Inc
F:0OP
|
US |
|
Wi2wi Corp
OTC:ISEYF
|
US |
|
T
|
Tetra Bio Pharma Inc
F:JAM1
|
CA |
|
V
|
Valor Resources Ltd
SWB:LFY
|
AU |
|
W
|
Wiselink Co Ltd
TPEX:8932
|
TW |
|
C
|
CPT Drives And Power PCL
SET:CPT
|
TH |
|
E
|
Easycall.pl SA
WSE:ECL
|
PL |
|
S
|
Soosung Salvacion Co Ltd
KOSDAQ:084180
|
KR |
|
C
|
Citizens Bancorp
OTC:CZNB
|
US |
|
P
|
PT Wahana Interfood Nusantara Tbk
IDX:COCO
|
ID |
|
N
|
Nuwellis Inc
F:22S
|
US |
Bankruptcy Probability
Eagle Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Eagle Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Eagle Pharmaceuticals Inc
NASDAQ:EGRX
|
7.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Eagle Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Eagle Pharmaceuticals Inc has total debt of 61.9m USD. This includes both short-term (0 USD) and long-term (61.9m USD) debt.
You can find a full breakdown on its Balance Sheet.
